insights_auto
Nega MVIR oshdi 2,33%?
Batafsil oʻrganishchevron_right
MVIR:STO
Medivir AB
1,49 SEK
arrow_upward
+2,33%(+0,034) 1K
9-okt, 17:29:42 (GMT+2) · SEK
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoMVIR tikeri uchun statistika yaratilmoqda...
Ochish
1,47 SEK
Yuqori
1,50 SEK
Past
1,45 SEK
Bozor kapitali
932,52 mln
Oʻrtacha hajm
1,41 mln
Hajmi
1,73 mln
52 haftalik eng yuqori
2,88 SEK
52 haftalik eng past
0,34 SEK
Aksiya boʻyicha daromad
-0,37 SEK
Muomaladagi aksiyalar
624,18 mln
Xodimlar soni
6
Ochish
1,47 SEK
Yuqori
1,50 SEK
Past
1,45 SEK
Bozor kapitali
932,52 mln
Oʻrtacha hajm
1,41 mln
Hajmi
1,73 mln
52 haftalik eng yuqori
2,88 SEK
52 haftalik eng past
0,34 SEK
Aksiya boʻyicha daromad
-0,37 SEK
Muomaladagi aksiyalar
624,18 mln
Xodimlar soni
6
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Yahoo Finance
·
1 soat oldin
Terminal1, the operating system built for public companies, announced today that U.S Gold Corp (NASDAQ:USAU) has joined the Terminal1 platform
MarketWatch
·
12 daqiqa oldin
Why you need to take a closer look at your favorite stock index
Breakingthenews.net
·
32 daqiqa oldin
Dow leads gains on Wall Street, surges 400 points
Nasdaq
·
5 soat oldin
WISeSat.Space Holdings Corp. Rings the Opening Bell
Profil
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies.
Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.
Medivir is listed on the Nasdaq Stockholm Mid Cap List.
In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
Medivir AB haqida